Building the evidence to inform clinical practice worldwide: in conversation with Laurent Billot | The George Institute for Global Health. 19 May 2022. https://www.georgeinstitute.org/news-and-media/news/building-the-evidence-to-inform-clinical-practice-worldwide-in-conversation-with-laurent-billot. Accessed 14 July 2025.

Moore TJ, Zhang H, Anderson G, Alexander GC. Estimated costs of pivotal trials for novel therapeutic agents approved by the US Food and Drug Administration, 2015-2016. JAMA Intern Med. 2018;178(11):1451–7. https://doi.org/10.1001/jamainternmed.2018.3931.

Article  PubMed  PubMed Central  Google Scholar 

Minelli C, Baio G. Value of information: a tool to improve research prioritization and reduce waste. PLoS Med. 2015;12(9):e1001882. https://doi.org/10.1371/journal.pmed.1001882.

Article  PubMed  PubMed Central  Google Scholar 

Wilson ECF. A practical guide to value of information analysis. Pharmacoeconomics. 2015;33(2):105–21. https://doi.org/10.1007/s40273-014-0219-x.

Article  PubMed  Google Scholar 

Fenwick E, Steuten L, Knies S, et al. Value of information analysis for research decisions—an introduction: report 1 of the ISPOR value of information analysis emerging good practices task force. Value Health. 2020;23(2):139–50. https://doi.org/10.1016/j.jval.2020.01.001.

Article  PubMed  Google Scholar 

Sanders GD, Neumann PJ, Basu A, et al. Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine. JAMA. 2016;316(10):1093–103. https://doi.org/10.1001/jama.2016.12195.

Article  PubMed  Google Scholar 

Reddy KP, Denkinger CM, Broger T, et al. Cost-effectiveness of a novel lipoarabinomannan test for tuberculosis in patients with human immunodeficiency virus. Clin Infect Dis. 2021;73(7):e2077–85. https://doi.org/10.1093/cid/ciaa1698.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chapman RH, Berger M, Weinstein MC, Weeks JC, Goldie S, Neumann PJ. When does quality-adjusting life-years matter in cost-effectiveness analysis? Health Econ. 2004;13(5):429–36. https://doi.org/10.1002/hec.853.

Article  PubMed  Google Scholar 

GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1545–602. https://doi.org/10.1016/S0140-6736(16)31678-6.

Article  Google Scholar 

GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1459–544. https://doi.org/10.1016/S0140-6736(16)31012-1.

Article  Google Scholar 

Menzies NA, Gomez GB, Bozzani F, et al. Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models. Lancet Glob Health. 2016;4(11):e816–26. https://doi.org/10.1016/S2214-109X(16)30265-0.

Article  PubMed  PubMed Central  Google Scholar 

Pei PP, Fitzmaurice KP, Le MH, et al. The value-of-information and value-of-implementation from clinical trials of diagnostic tests for HIV-associated tuberculosis: a modeling analysis. MDM Policy Pract. 2023;8(2):23814683231198873. https://doi.org/10.1177/23814683231198873.

Article  PubMed  PubMed Central  Google Scholar 

Grimm SE, Dixon S, Stevens JW. Assessing the expected value of research studies in reducing uncertainty and improving implementation dynamics. Med Decis Mak. 2017;37(5):523–33. https://doi.org/10.1177/0272989X16686766.

Article  Google Scholar 

Andronis L, Barton PM. Adjusting estimates of the expected value of information for implementation: theoretical framework and practical application. Med Decis Mak. 2016;36(3):296–307. https://doi.org/10.1177/0272989X15614814.

Article  Google Scholar 

Gupta-Wright A, Fielding KL, van Oosterhout JJ, et al. Rapid urine-based screening for tuberculosis to reduce AIDS-related mortality in hospitalized patients in Africa (the STAMP trial): study protocol for a randomised controlled trial. BMC Infect Dis. 2016;16:501. https://doi.org/10.1186/s12879-016-1837-z.

Article  PubMed  PubMed Central  Google Scholar 

Singhroy DN, MacLean E, Kohli M, et al. Adoption and uptake of the lateral flow urine LAM test in countries with high tuberculosis and HIV/AIDS burden: current landscape and barriers. Gates Open Res. 2020;4:24. https://doi.org/10.12688/gatesopenres.13112.2.

Article  PubMed  PubMed Central  Google Scholar 

World Health Organization. Lateral flow urine lipoarabinomannan assay (LF-LAM) for the diagnosis of active tuberculosis in people living with HIV: policy update 2019. Published online 2019. https://iris.who.int/handle/10665/329479. Accessed 14 July 2025.

Broger T, Sossen B, du Toit E, et al. Novel lipoarabinomannan point-of-care tuberculosis test for people with HIV: a diagnostic accuracy study. Lancet Infect Dis. 2019;19(8):852–61. https://doi.org/10.1016/S1473-3099(19)30001-5.

Article  PubMed  PubMed Central  Google Scholar 

Gupta-Wright A, Corbett EL, van Oosterhout JJ, et al. Rapid urine-based screening for tuberculosis in HIV-positive patients admitted to hospital in Africa (STAMP): a pragmatic, multicentre, parallel-group, double-blind, randomised controlled trial. Lancet. 2018;392(10144):292–301. https://doi.org/10.1016/S0140-6736(18)31267-4.

Article  PubMed  PubMed Central  Google Scholar 

Reddy KP, Gupta-Wright A, Fielding KL, et al. Cost-effectiveness of urine-based tuberculosis screening in hospitalised patients with HIV in Africa: a microsimulation modelling study. Lancet Glob Health. 2019;7(2):e200–8. https://doi.org/10.1016/S2214-109X(18)30436-4.

Article  PubMed  PubMed Central  Google Scholar 

Ford N, Matteelli A, Shubber Z, et al. TB as a cause of hospitalization and in-hospital mortality among people living with HIV worldwide: a systematic review and meta-analysis. J Int AIDS Soc. 2016;19(1):20714. https://doi.org/10.7448/IAS.19.1.20714.

Article  PubMed  PubMed Central  Google Scholar 

Kerkhoff AD, Barr DA, Schutz C, et al. Disseminated tuberculosis among hospitalised HIV patients in South Africa: a common condition that can be rapidly diagnosed using urine-based assays. Sci Rep. 2017;7(1):10931. https://doi.org/10.1038/s41598-017-09895-7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cox HS, McDermid C, Azevedo V, et al. Epidemic levels of drug resistant tuberculosis (MDR and XDR-TB) in a high HIV prevalence setting in Khayelitsha, South Africa. PLoS One. 2010;5(11):e13901. https://doi.org/10.1371/journal.pone.0013901.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boyles TH, Griesel R, Stewart A, Mendelson M, Maartens G. Incremental yield and cost of urine determine TB-LAM and sputum induction in seriously ill adults with HIV. Int J Infect Dis. 2018;75:67–73. https://doi.org/10.1016/j.ijid.2018.08.005.

Article  PubMed  PubMed Central  Google Scholar 

Katagira W, Walter ND, den Boon S, et al. Empiric TB treatment of severely ill patients with HIV and presumed pulmonary TB improves survival. JAIDS J Acquir Immune Defic Syndr. 2016;72(3):297–303. https://doi.org/10.1097/QAI.0000000000000970.

Article  PubMed  PubMed Central  Google Scholar 

Reddy KP, Horsburgh CR, Wood R, et al. Shortened tuberculosis treatment for people with HIV in South Africa. A model-based evaluation and cost-effectiveness analysis. Ann Am Thorac Soc. 2020;17(2):202–11. https://doi.org/10.1513/AnnalsATS.201905-418OC.

Article  PubMed  PubMed Central  Google Scholar 

Claassens MM, du Toit E, Dunbar R, et al. Tuberculosis patients in primary care do not start treatment. What role do health system delays play? Int J Tuberc Lung Dis. 2013;17(5):603–7. https://doi.org/10.5588/ijtld.12.0505.

Article  CAS  PubMed  Google Scholar 

Pepper DJ, Marais S, Bhaijee F, Wilkinson RJ, De Azevedo V, Meintjes G. Assessment at antiretroviral clinics during TB treatment reduces loss to follow-up among HIV-infected patients. PLoS One. 2012;7(6):e37634. https://doi.org/10.1371/journal.pone.0037634.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lawn SD, Kranzer K, Edwards DJ, McNally M, Bekker LG, Wood R. Tuberculosis during the first year of antiretroviral therapy in a South African cohort using an intensive pretreatment screening strategy. AIDS. 2010;24(9):1323–8. https://doi.org/10.1097/QAD.0b013e3283390dd1.

Article  PubMed  PubMed Central